✦ LIBER ✦

Health-Related Quality Of Life Of Japanese Patients With Primary Immunodeficiency Diseases Receiving IgPro20, a 20% Liquid Subcutaneous Immunoglobulin (Hizentra®)

✍ Scribed by Kanegane, Hirokazu; Imai, Kohsuke; Yamada, Masafumi; Takada, Hidetoshi; Ariga, Tadashi; Igarashi, Ataru; Tsutani, Kiichiro; Bexon, Martin; Rojavin, Mikhail; Kobayashi, Midori; Lawo, John-Philip; Zbrozek, Art; Nonoyama, Shigeaki; Hara, Toshiro; Miyawaki, Toshio

Book ID: 122240323
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 42 KB
Volume: 133
Category: Article
ISSN: 1097-6825
DOI: 10.1016/j.jaci.2013.12.646

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of IgPro20, a Subcut

Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency Diseases

✍ Kanegane, Hirokazu; Imai, Kohsuke; Yamada, Masafumi; Takada, Hidetoshi; Ariga, T 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 212 KB

Erratum to: Efficacy and Safety of IgPro

Erratum to: Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency Diseases

✍ Kanegane, Hirokazu; Imai, Kohsuke; Yamada, Masafumi; Takada, Hidetoshi; Ariga, T 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 51 KB

Efficacy and Safety of a New 20% Immunog

Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency

✍ John B. Hagan; Mary B. Fasano; Sheldon Spector; Richard L. Wasserman; Isaac Mela 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 197 KB

Efficacy and Safety of a New 20% Immunog

Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients with Primary Immunodeficiency

✍ Hagan, J.; Fasano, M.B.; Spector, S.; Wasserman, R.L.; Melamed, I.; Rojavin, M.A 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Efficacy and Safety of IgPro20, a 20% Im

Efficacy and Safety of IgPro20, a 20% Immunoglobulin for Subcutaneous Administration, in Patients with Primary Immunodeficiency Switching from Intravenous Replacement Therapy

✍ Stephen Jolles; Victor Cristea; Volker Wahn; Marianne Debré; Hilary Longhurst; O 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Efficacy and Safety of Hizentra®, a New

Efficacy and Safety of Hizentra®, a New 20% Immunoglobulin Preparation for Subcutaneous Administration, in Pediatric Patients with Primary Immunodeficiency

✍ Michael Borte; Malgorzata Pac; Margit Serban; Teresa Gonzalez-Quevedo; Bodo Grim 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 182 KB